硫利达嗪对乳腺癌细胞MDA-MB-231和MCF-7的杀伤效应 |
| |
引用本文: | 童斯浩,汪毅,龚理,钱振珏,柯章敏,鲍扬漪. 硫利达嗪对乳腺癌细胞MDA-MB-231和MCF-7的杀伤效应[J]. 安徽医科大学学报, 2015, 0(4) |
| |
作者姓名: | 童斯浩 汪毅 龚理 钱振珏 柯章敏 鲍扬漪 |
| |
作者单位: | 1. 安徽医科大学第三附属医院肿瘤科,合肥,230061;2. 安徽医科大学附属省立医院肿瘤科,合肥,230001 |
| |
摘 要: | 目的观察硫利达嗪对人乳腺癌细胞MDA-MB-231和MCF-7的凋亡作用,并探讨其机制。方法采用MTT法测定硫利达嗪对细胞的抑制作用,计算半数抑制浓度( IC50);流式细胞术检测硫利达嗪对细胞周期分布和凋亡的影响;比色法测定药物对细胞Caspase-3活性的影响;West-ern blot法检测凋亡调节蛋白Bcl-2、Bax表达的变化。结果 硫利达嗪作用24 h后, MDA-MB-231、MCF-7细胞增殖明显呈剂量依赖性抑制,其IC50为18、22μmol/L。流式细胞术结果显示,随着加入硫利达嗪浓度的提高, MDA-MB-231、MCF-7细胞均发生不同程度的G0/G1期阻滞、细胞凋亡程度增加及伴随胞内Caspase-3活性增加。各实验组与对照组比较,差异均有统计学意义(P<0.01)。 Western blot法结果显示随着药物浓度的增加,抗凋亡蛋白Bcl-2表达下调、促凋亡蛋白Bax表达明显上调,各实验组与对照组相比,差异有统计学意义( P <0.01)。结论硫利达嗪对乳腺癌细胞MDA-MB-231、MCF-7有显著的增殖抑制作用且可显著诱导肿瘤细胞发生G0/G1期阻滞及凋亡,伴随Caspase-3活性的上调,其毒性机制可能与肿瘤细胞内抗凋亡蛋白 Bcl-2下调、Bax上调有关。
|
关 键 词: | 乳腺癌 硫利达嗪 周期 凋亡 Caspase-3 Bcl-2 Bax |
Killing effect of thioridazine on the proliferation of breast cancer cells MDA-MB-231 and MCF-7 |
| |
Abstract: | Objectives To investigate the anti-proliferative and apoptosis-inducing effects and the possible molecular mechanisms of thioridazine on breast cancer cell lines MDA-MB-231 and MCF-7. Methods The anti-proliferative effects of thioridazine on MDA-MB-231 and MCF-7 cells were measured with MTT and the values of IC50 were calcu-lated. Flow cytometry was used to measure the cell cycle arresting and apoptosis . Caspase -3 activity assay kit was performed to detect Caspase-3 activity levels. The expression changes of the Bcl-2 and Bax were detected by western blot. Results After treated with thioridazine for 24 h, MDA-MB-231 and MCF-7 cells were significantly inhibited by the drug extracts. The values of IC50 were respectively 18μmol/L and 22μmol/L. Flow cytometry showed cells’ G0/G1 phase arrest along with an increase of apoptosis and intracellular Caspase-3 activity with the increase of thio-ridazine concentration. Western blot showed concentration-dependant decrease in Bcl-2 and increase in Bax proteins. Each experimental group compared with the control group, the differences were statistically significant (P<0. 01). Conclusion Thioridazine has obvious cytotoxic effect on breast cancer cells MDA-MB-231 and MCF-7. It obviously induces breast cancer cells G0/G1 phase arresting and apoptosis, accompanied by up-regulation of Caspase-3 activity. The mechanism may be related to the down-regulation of Bcl-2 and up-regulation of Bax. |
| |
Keywords: | breast cancer thioridazine cell cycle apoptosis Caspase-3 Bcl-2 Bax |
本文献已被 万方数据 等数据库收录! |